Operating Lease, Right-of-Use Asset of Insight Molecular Diagnostics Inc. from 30 Sep 2019 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Insight Molecular Diagnostics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 30 Sep 2023.
  • Insight Molecular Diagnostics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2023 was $4,036,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $4,036,000 +$537,000 +15% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $4,036,000 +$537,000 +15% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $3,499,000 $0 0% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $3,499,000 $0 0% 31 Dec 2022 10-Q 09 Nov 2023 2023 Q3
Q3 2022 $3,499,000 $0 0% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $3,499,000 +$102,000 +3% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $3,499,000 +$102,000 +3% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $3,499,000 +$102,000 +3% 31 Dec 2021 10-K 12 Apr 2023 2022 FY
Q3 2021 $3,499,000 +$102,000 +3% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $3,397,000 $0 0% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $3,397,000 +$6,000 +0.18% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $3,397,000 +$541,000 +19% 31 Dec 2020 10-Q 09 Nov 2021 2021 Q3
Q3 2020 $3,397,000 +$3,000,000 +756% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $3,397,000 30 Jun 2020 10-Q 29 Jul 2020 2020 Q2
Q1 2020 $3,391,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $2,856,000 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q3 2019 $397,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.